Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C5H10O5 |
Molecular Weight | 150.1299 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@@H](O)[C@H](O)[C@@H](O)C=O
InChI
InChIKey=PYMYPHUHKUWMLA-VPENINKCSA-N
InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5+/m0/s1
Molecular Formula | C5H10O5 |
Molecular Weight | 150.1299 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: Description was created based on several sources, including
http://www.jbc.org/content/98/1/133.full.pdf |
https://www.ncbi.nlm.nih.gov/pubmed/3286361
Curator's Comment: Description was created based on several sources, including
http://www.jbc.org/content/98/1/133.full.pdf |
https://www.ncbi.nlm.nih.gov/pubmed/3286361
D-Xylose is a sugar originally isolated from wood. D-Xylose is a colorless to white crystalline powder that is used in food products such as breads, butter, and beverage industry as flavoring agent and sweetener. Specifically, D-Xylose is used to sweeten products intended for use by obese and diabetic customers because it is a non-caloric sweetener. It has a cool and refreshing taste and has the same sweetness as sucrose, and it is often used to sweeten a wide variety of foods and beverages such as spices, meat products, butter, etc. D-Xylose is a sugar widely used as diabetic sweetener in food and beverage. is a sugar first isolated from wood, and named for it. Xylose is classified as a monosaccharide of the aldopentose type, which means that it contains five carbon atoms and includes a formyl functional group. It is derived from hemicellulose, one of the main constituents of biomass. Like most sugars, it can adopt several structures depending on conditions. With its free carbonyl group, it is a reducing sugar. D-xylose absorbtion test has been used for diagnosis of intestinal malabsorption.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q86Y38 Gene ID: 64131.0 Gene Symbol: XYLT1 Target Organism: Homo sapiens (Human) |
|||
Target ID: Q9H1B5 Gene ID: 64132.0 Gene Symbol: XYLT2 Target Organism: Homo sapiens (Human) |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | XYLO-PFAN Approved UseXylose Absorption Test (Adult - 25g dose). Nonstandard test for determining cause of malabsorption. Launch Date3.78691191E11 |
PubMed
Title | Date | PubMed |
---|---|---|
[Characteristics of disease and involution-induced changes in intestinal absorption]. | 1986 Jul-Aug |
|
[The value of the d-xylose loading test in the diagnosis of malabsorption syndromes]. | 1990 Aug 19 |
|
Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment. | 1998 Aug |
|
Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. | 2001 Jul |
|
Fumagillin treatment of intestinal microsporidiosis. | 2002 Jun 20 |
Sample Use Guides
Xylose Absorption Test for determining cause of malabsorption. The participant will be asked to drink 8 ounces (240 ml) of water that contains 25 grams of a sugar called d-xylose. The amount of d-xylose that comes out in your urine over the next 5 hours will be measured. The participant may have a blood sample collected at 1 and 3 hours after drinking the liquid. The amount of urine produced over a 5-hour period is also determined.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28126230
To clarify the relationship between NAD(P)+/NAD(P)H redox balances and the metabolisms of xylose or xylitol as carbon sources, authors analyzed aerobic and anaerobic batch cultures of recombinant Saccharomyces cerevisiae in a complex medium containing 20 g/L xylose or 20 g/L xylitol at pH 5.0 and 30°C.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:00:55 UTC 2023
by
admin
on
Fri Dec 15 16:00:55 UTC 2023
|
Record UNII |
A1TA934AKO
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
47806-5
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
||
|
DSLD |
3459 (Number of products:18)
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
||
|
LOINC |
3134-4
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
||
|
NCI_THESAURUS |
C68484
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
||
|
LOINC |
25556-2
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
||
|
LOINC |
32347-7
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
||
|
LOINC |
29999-0
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
||
|
LOINC |
3135-1
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
||
|
CFR |
21 CFR 862.1820
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
||
|
LOINC |
75051-3
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
||
|
LOINC |
12274-7
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
122762
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
CHEMBL502135
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
58-86-6
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
644160
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
11378
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | RxNorm | ||
|
200-400-7
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
18222
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
SUB130166
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
D014994
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
SUB15738MIG
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
53455
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
A1TA934AKO
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
DTXSID0023745
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
3273
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
DB09419
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
2854
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
m11555
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | Merck Index | ||
|
36441-93-7
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
ALTERNATIVE | |||
|
7261-26-9
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
ALTERNATIVE | |||
|
C66674
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
XYLOSE
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
15936
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
A1TA934AKO
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
1722005
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY | |||
|
100000156317
Created by
admin on Fri Dec 15 16:00:55 UTC 2023 , Edited by admin on Fri Dec 15 16:00:55 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
LABELED -> NON-LABELED |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |